HCL inks deal with Purdue Pharma

NEW DELHI: Noida-based technology services provider HCL Technologies on Tuesday announced a multimillion dollar deal with USbased Purdue Pharma to manage its data centres across the United States.

The deal indicates a resurgence in interest of CIOs in US pharma industry to spend their discretionary budgets to cut costs, even as the fiscal in US comes to a close.

Estimated to have sales of over $2 billion, and based in Connecticut , privately-held Purdue Pharma is known the worldover for its Betadeine brand of topical antiseptic solutions.

“It is a multi-year end-to-end IT infrastructure management engagement and covers management of two data centers and all remote locations of Purdue in the US,” Pradeep Bindal, senior VP and global head of sales at HCL Technologies Infrastructure Services Division told ET.

HCL Tech stock went up 2.6% on the BSE post announcement of the deal, late afternoon on Tuesday.